We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
Statement of APC Chief Executive Officer Scott Brunner, CAE, on statements by Eli Lilly claiming an unknown impurity in sampled tirzepatide + B12 ...
Download APC’s 2025–2026 Snapshot of Pharmacy Compounding in America to explore the latest trends in compounded medications, drug shortages, ...
It’s time — time to get started on your application for the APC Fellows Program.
Anti-compounding bills are being considered in Indiana, Kentucky, and Colorado (and other places) — here's the latest.
It ain't just us — several lawyers who know this stuff are confused by the FDA's two statements about cracking down on compounding.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
